bit.bio raises €27.0M Bridge round

The capital is intended to accelerate bit.bio's transformation into a leading provider of human cells for research and drug discovery and to support its transition from the private market to the public world.

Source: https://bit.bio/news-and-events/bit.bio-raises-30-million-led-by-m-and-g-investments/